Literature DB >> 24764669

Case-control study of factors that trigger inflammatory bowel disease flares.

Linda A Feagins1, Ramiz Iqbal1, Stuart J Spechler1.   

Abstract

AIM: To explore the association between inflammatory bowel diseases (IBD) flares and potential triggers.
METHODS: Patients evaluated for an acute flare of IBD by a gastroenterologist at the Dallas VA Medical Center were invited to participate, as were a control group of patients with IBD in remission. Patients were systematically queried about nonsteroidal anti-inflammatory drug use, antibiotic use, stressful life events, cigarette smoking, medication adherence, infections, and travel in the preceding 3 mo. Disease activity scores were calculated for each patient at the time of enrollment and each patient's chart was reviewed. Multivariate regression analysis was performed.
RESULTS: A total of 134 patients with IBD (63 with Crohn's disease, 70 with ulcerative colitis, and 1 with indeterminate colitis) were enrolled; 66 patients had flares of their IBD and 68 were controls with IBD in remission (for Crohn's patients, average Crohn's disease activity index was 350 for flares vs 69 in the controls; for UC patients, Mayo score was 7.6 for flares vs 1 for controls in those with full Mayo available and 5.4p for flares vs 0.1p for controls in those with partial Mayo score). Only medication non-adherence was significantly more frequent in the flare group than in the control group (48.5% vs 29.4%, P = 0.03) and remained significant on multivariate analysis (OR = 2.86, 95%CI: 1.33-6.18). On multivariate regression analysis, immunomodulator use was found to be associated with significantly lower rates of flare (OR = 0.40, 95%CI: 0.19-0.86).
CONCLUSION: In a study of potential triggers for IBD flares, medication non-adherence was significantly associated with flares. These findings are incentive to improve medication adherence.

Entities:  

Keywords:  Crohn’s disease; Flare; Inflammatory bowel diseases; Non-adherence; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24764669      PMCID: PMC3989967          DOI: 10.3748/wjg.v20.i15.4329

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  Impact of cessation of smoking on the course of ulcerative colitis.

Authors:  L Beaugerie; N Massot; F Carbonnel; S Cattan; J P Gendre; J Cosnes
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

Review 2.  Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease?

Authors:  Linda A Feagins; Byron L Cryer
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

3.  Effects of current and former cigarette smoking on the clinical course of Crohn's disease.

Authors:  J Cosnes; F Carbonnel; F Carrat; L Beaugerie; S Cattan; J Gendre
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

4.  Factors that modify therapy adherence in patients with inflammatory bowel disease.

Authors:  Fernando Bermejo; Antonio López-San Román; Alicia Algaba; Iván Guerra; Paz Valer; Silvia García-Garzón; Belén Piqueras; Carlos Villa; Andrea Bermejo; José L Rodríguez-Agulló
Journal:  J Crohns Colitis       Date:  2010-02-12       Impact factor: 9.071

Review 5.  Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review.

Authors:  C A Jackson; J Clatworthy; A Robinson; Rob Horne
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

6.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Authors:  K W Schroeder; W J Tremaine; D M Ilstrup
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice.

Authors:  S Melgar; K Engström; A Jägervall; V Martinez
Journal:  Stress       Date:  2008-09       Impact factor: 3.493

Review 9.  Clostridium difficile and inflammatory bowel disease.

Authors:  Mazen Issa; Ashwin N Ananthakrishnan; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

10.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16
View more
  13 in total

1.  A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis.

Authors:  David T Rubin; Cindy Traboulsi; Victoria Rai
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-02

2.  Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.

Authors:  Steven J Edwards; Samantha Barton; Mariana Bacelar; Charlotta Karner; Peter Cain; Victoria Wakefield; Gemma Marceniuk
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

3.  Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation.

Authors:  O O Moninuola; W Milligan; P Lochhead; H Khalili
Journal:  Aliment Pharmacol Ther       Date:  2018-04-05       Impact factor: 8.171

4.  Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn's Disease.

Authors:  Ana Gutiérrez; Pedro Zapater; Oriol Juanola; Laura Sempere; Marifé García; Raquel Laveda; Antonio Martínez; Michael Scharl; José M González-Navajas; José Such; Reiner Wiest; Gerhard Rogler; Rubén Francés
Journal:  Am J Gastroenterol       Date:  2016-02-23       Impact factor: 10.864

Review 5.  Influence of environmental factors on the onset and course of inflammatory bowel disease.

Authors:  Amit Kumar Dutta; Ashok Chacko
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

6.  Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study.

Authors:  Pierre Michetti; John Weinman; Ulrich Mrowietz; Josef Smolen; Laurent Peyrin-Biroulet; Edouard Louis; Dieter Schremmer; Namita Tundia; Pascal Nurwakagari; Nicole Selenko-Gebauer
Journal:  Adv Ther       Date:  2016-11-16       Impact factor: 3.845

7.  The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.

Authors:  Cheryl Kluthe; Jenkin Tsui; Donald Spady; Matthew Carroll; Eytan Wine; Hien Quoc Huynh
Journal:  Can J Gastroenterol Hepatol       Date:  2018-02-25

8.  The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.

Authors:  Marie Skov Kristensen; Thora Majlund Kjærulff; Annette Kjær Ersbøll; Anders Green; Jesper Hallas; Lau Caspar Thygesen
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

Review 9.  Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review.

Authors:  Andrew Lukas Yin; David Hachuel; John P Pollak; Ellen J Scherl; Deborah Estrin
Journal:  J Med Internet Res       Date:  2019-08-19       Impact factor: 5.428

Review 10.  Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis.

Authors:  Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2015-11-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.